Endocrine System Articles A-Z
Precautions and Warnings With Pioglitazone and Glimepiride
This eMedTV page lists precautions and warnings with pioglitazone and glimepiride to be aware of before taking it. The list includes possible side effects, such as low blood sugar and weight gain, and people who should not take the drug.
Precautions and Warnings With Pioglitazone and Metformin
This eMedTV resource provides precautions and warnings with pioglitazone and metformin to be aware of, including who should not take the drug and possible side effects. For example, people with kidney disease should not take the medication.
Precautions and Warnings With Pramlintide
Some precautions and warnings with pramlintide concern allergic reactions that the drug may cause. This eMedTV segment discusses warnings and precautions to be aware of with pramlintide, such as those involving low blood sugar.
Precautions and Warnings With Repaglinide
This eMedTV segment describes several precautions and warnings with repaglinide, such as the potential for allergic reactions, possible side effects, and the danger of taking the drug when pregnant. This page also lists those who should not take it.
Precautions and Warnings With Rosiglitazone
This portion of the eMedTV archives examines several precautions and warnings with rosiglitazone, including potential drug interactions, possible weight gain, and the danger of increased liver enzymes. This page also lists who should avoid the drug.
Precautions and Warnings With Rosiglitazone and Glimepiride
This eMedTV page takes an in-depth look at several precautions and warnings with rosiglitazone and glimepiride, including the danger of taking the drug while pregnant and possible allergic reactions. This page also covers who should avoid the drug.
Precautions and Warnings With Rosiglitazone and Metformin
A rare but possible side effect of rosiglitazone and metformin is low blood sugar. This eMedTV page contains more precautions and warnings with rosiglitazone and metformin, and offers a list of certain people who should not take the diabetes drug.
This eMedTV segment discusses primary adrenal insufficiency, a condition in which the adrenal glands stop making hormones that are important for certain bodily functions. This article offers a detailed description of this condition.
A prolactinoma is a common, non-cancerous tumor affecting the pituitary gland. This eMedTV article discusses prolactinomas in detail, including information about symptoms they may cause and treatment options for the tumors.
Prolactinoma and Birth Control Pills
To date, no research has suggested a link between prolactinoma and birth control pills. This eMedTV article discusses how, in fact, estrogen replacement therapy is a safe treatment method for post-menopausal women with prolactinomas.
Careful monitoring (including MRIs) is vital for any woman dealing with both a prolactinoma and pregnancy. This eMedTV article discusses the risks involved with a prolactinoma during pregnancy and suggests ways to reduce them.
For women with prolactinoma, symptoms may include changes in changes in menstruation. As this eMedTV article explains, symptoms of a prolactinoma in men may begin with impotence and decreased libido before progressing to more severe symptoms.
In most cases, prolactinoma treatment begins with medications such as bromocriptine or cabergoline. As this eMedTV article explains, other options for treating a prolactinoma include surgery and radiation therapy.
Repaglinide is a prescription drug that is licensed to lower blood sugar in people with type 2 diabetes. This eMedTV Web page explains how the drug works to increase insulin production, lists potential side effects, and offers tips on taking it.
As this eMedTV page explains, the recommended starting repaglinide dose is generally 0.5 mg, taken before each meal. However, the repaglinide dosing amount may be higher based on certain blood tests. This page also offers tips on taking the medicine.
Rosiglitazone is a prescription medicine that lowers blood sugar levels in people with type 2 diabetes. This eMedTV article explains how rosiglitazone works, covers potential side effects, and offers some tips on when and how to take the medication.
Rosiglitazone and glimepiride is a prescription medication that is approved to treat type 2 diabetes. This eMedTV resource explains how rosiglitazone and glimepiride works to lower blood sugar levels and lists some potential side effects of the drug.
Rosiglitazone and Glimepiride Dosage
This eMedTV Web page explains that the usual starting rosiglitazone and glimepiride dosage is 4 mg/1 mg once a day. This page also describes some tips on when and how to take the medication and explains how your dosage will be determined.
Rosiglitazone and Glimepiride Drug Info
Rosiglitazone and metformin is a medicine that can be prescribed to treat type 2 diabetes in adults. This eMedTV Web page explains how rosiglitazone and metformin works and offers general dosing information and precautions for the drug.
Rosiglitazone and Metformin Dosage
Most people start with a rosiglitazone and metformin dosage of 2 mg/500 mg once or twice daily. This eMedTV page also offers dosing recommendations for those who are switching to the combination drug from just metformin or just rosiglitazone.
Rosiglitazone and Metformin Info
This eMedTV article explains that the recommended starting rosiglitazone dosage is 4 mg once daily (or 2 mg twice daily). This Web page outlines some rosiglitazone dosing guidelines and gives some tips on when and how to take the drug.